Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Chapter 4 Preparation of Isolated Rat Liver Cells
1976 Standout
Sonographic fatty liver, overweight and ischemic heart disease
2005
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
2023 Standout
Acute Pancreatitis and Normoamylasemia
1989
Therapeutic elevation of HDL-cholesterol to prevent atherosclerosis and coronary heart disease
2006
Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds
2005
Rosuvastatin in the management of hyperlipidemia
2004
The safety of statins in clinical practice
2007
Marked Variability of Monacolin Levels in Commercial Red Yeast Rice Products
2010
Traditional Chinese Medicine for Cardiovascular Disease
2017 Standout
Platelet adhesion in atrial fibrillation
2007
Effects of Torcetrapib in Patients at High Risk for Coronary Events
2007 Standout
The Failing Heart — An Engine Out of Fuel
2007 Standout
Prospects for Cardiovascular Research
2001 StandoutNobel
Correlation of Findings from Iodine 123 Scan and Ultrasonography in the Recommendation for Thyroid Fine-Needle Aspiration Biopsy
2011
Mechanism of Action of Niacin
2008
The metabolic syndrome
2010 Standout
Antiatherothrombotic effects of nicotinic acid
2003
Once‐Daily Niacin Extended Release/Lovastatin Combination Tablet Has More Favorable Effects on Lipoprotein Particle Size and Subclass Distribution Than Atorvastatin and Simvastatin
2003
Statins and C‐Reactive Protein Levels
2007
Intestinal Lymphatic Transport of Halofantrine Occurs After Oral Administration of a Unit-Dose Lipid-Based Formulation to Fasted Dogs
2003
Animal models for the study of intestinal lymphatic drug transport
2001
Rosuvastatin for the Treatment of Hypercholesterolemia
2005
A dose‐ranging study of a new, once‐daily, dual‐component drug product containing niacin extended‐release and lovastatin
2003
Niacin treatment of the atherogenic lipid profile and Lp(a) in diabetes
2002
Niacin and fibrates in atherogenic dyslipidemia: Pharmacotherapy to reduce cardiovascular risk
2010
Acute Pancreatitis
2016 Standout
Traditional Chinese medication for cardiovascular disease
2014
Comparison of Outcomes After 123I Versus 131I Preablation Imaging Before Radioiodine Ablation in Differentiated Thyroid Carcinoma
2007
Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs
2007 Standout
Design of a novel class of biphenyl CETP inhibitors
2010
Identification of Bronchioalveolar Stem Cells in Normal Lung and Lung Cancer
2005 Standout
The metabolic syndrome
2005 Standout
Severe hypertriglyceridemia and pancreatitis: presentation and management
2009
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
2010 Standout
Combined therapy in the treatment of dyslipidemia
2009
Suppression of Niacin-induced Vasodilation with an Antagonist to Prostaglandin D2 Receptor Subtype 1
2007
Long-term safety and efficacy of a once-daily niacin/lovastatin formulation for patients with dyslipidemia**A complete list of participants in the Research Group and Publication Committee appears in the Appendix.
2002
Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid – a position paper developed by the European Consensus Panel on HDL-C*
2004
The safety of over-the-counter niacin. A randomized placebo-controlled trial [ISRCTN18054903]
2003
Effects of a niacin receptor partial agonist, MK-0354, on plasma free fatty acids, lipids, and cutaneous flushing in humans
2008
New Therapies for Reducing Low-Density Lipoprotein Cholesterol
2014
Efficacy, Safety, and Tolerability of Once-Daily Niacin for the Treatment of Dyslipidemia Associated With Type 2 Diabetes<subtitle>Results of the Assessment of Diabetes Control and Evaluation of the Efficacy of Niaspan Trial</subtitle>
2002
Lipid-Altering Efficacy and Safety of Ezetimibe/Simvastatin Coadministered With Extended-Release Niacin in Patients With Type IIa or Type IIb Hyperlipidemia
2008
Bile Increases Intestinal Lymphatic Drug Transport in the Fasted Rat
2005
Acute Pancreatitis
1994 Standout
Comparison of Once-Daily, niacin Extended-Release/lovastatin with standard doses of atorvastatin and simvastatin (the advicor versus other Cholesterol-Modulating agents trial evaluation [ADVOCATE])
2003
Role of Rab GTPases in Membrane Traffic
1997
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
2010 Standout
β-Arrestin1 mediates nicotinic acid–induced flushing, but not its antilipolytic effect, in mice
2009 StandoutNobel
Niacin therapy in atherosclerosis
2004
A prospective cohort study on risk of acute pancreatitis related to serum triglycerides, cholesterol and fasting glucose
2012
Effect of Short‐, Medium‐, and Long‐Chain Fatty Acid‐Based Vehicles on the Absolute Oral Bioavailability and Intestinal Lymphatic Transport of Halofantrine and Assessment of Mass Balance in Lymph‐Cannulated and Non‐cannulated Rats
2000
New Perspectives on the Use of Niacin in the Treatment of Lipid Disorders
2004
Mass spectrometry‐based analytical tools for the molecular protein characterization of human plasma lipoproteins
2005
C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women
2000 Standout
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Safety Considerations with Niacin Therapy
2006
A comparison of the LDL-cholesterol lowering efficacy of plant stanols and plant sterols over a continuous dose range: Results of a meta-analysis of randomized, placebo-controlled trials
2011
Identification and characterization of rodent ABCA1 in isolated type II pneumocytes
2003
Polyisoprenyl phosphates: natural antiinflammatory lipid signals
2002
Issues in Hyperlipidemic Pancreatitis
2003
Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis
2006 Standout
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
2009 Standout
Extended-release niacin treatment of the atherogenic lipid profile and lipoprotein(a) in diabetes
2002
Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
2015 Standout
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2
2004
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Insulin-Receptor Interaction in the Obese-Hyperglycemic Mouse
1973
The importance of the techniques employed during the enzymatic preparation of isolated liver parenchymal cells
1973
Increasing Levels of Interleukin (IL)-1Ra and IL-6 During the First 2 Days of Hospitalization in Unstable Angina Are Associated With Increased Risk of In-Hospital Coronary Events
1999
Type 2 diabetes: principles of pathogenesis and therapy
2005 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Synthesis of fatty acid synthetase by isolated liver cells obtained from rats in different nutritional or hormonal states
1973
Microsomal and cytosolic fractions of guinea pig hepatocytes contain 100-kilodalton GTP-binding proteins reactive with antisera against alpha subunits of stimulatory and inhibitory heterotrimeric GTP-binding proteins.
1990 StandoutNobel
Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol
2019 Standout
Triacylglycerol secretion in very low density lipoproteins by isolated rat liver parenchymal cells
1973
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Niacin therapy in atherosclerosis
2005
Advances in the Chemistry of Tetrahydroquinolines
2011 Standout
Oral Cholesteryl Ester Transfer Protein (CETP) Inhibitors: A Potential New Approach for Treating Coronary Artery Disease
2005
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Preparation of rat liver cells
1973
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
A rapid method for the isolation of large quantities of rat liver parenchymal cells with high anabolic rates
1972
Hormonal Control of Glycogenolysis and Gluconeogenesis in Isolated Rat Liver Cells
1973
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
1967 Standout
Membrane Fusion and Exocytosis
1999 StandoutNobel
Hyperlipidemic Pancreatitis
1990
Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts
2008 Standout
Ceramide inhibition of phospholipase D and its relationship to RhoA and ARF1 translocation in GTPγS-stimulated polymorphonuclear leukocytes
2003 StandoutNobel
Niacin, but Not Gemfibrozil, Selectively Increases LP-AI, a Cardioprotective Subfraction of HDL, in Patients With Low HDL Cholesterol
2001
Red Yeast Rice for Dyslipidemia in Statin-Intolerant Patients
2009
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Preparation of single-cell suspensions from normal liver, regenerating liver, and Morris hepatomas 9121 and 5123tc.
1972
A Prospective Study to Determine the Efficacy of Antibiotics in Acute Pancreatitis
1976
The management of congestive heart failure
1980
The Metabolic Syndrome
2008 Standout
Lactescence of serum following episodes of acute alcoholism and its probable relationship to acute pancreatitis
1957
Effect of different albumin‐bound fatty acids on fatty acid and cholesterol biosynthesis in rat hepatocytes
1974
Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative
2004
Biosynthesis of Fatty Acids and Cholesterol in Isolated Rat‐Liver Parenchymal Cells
1973
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Preparation of rat liver cells
1972
Cytoplasmic Structure and Contractility in Amoeboid Cells
1979
Feedback Regulation of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase in Livers of Mice Treated with Mevinolin, a Competitive Inhibitor of the Reductase
1980 StandoutNobel
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials
2012 Standout
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
2004 Standout
Preparation and biochemical characterization of parenchymal cells from rat liver
1973
Internal cell manipulation using infrared laser traps.
1989 StandoutNobel
Catecholamine-induced subsensitivity of adenylate cyclase associated with loss of beta-adrenergic receptor binding sites.
1975 StandoutNobel
Active and inactive forms of 3-hydroxy-3-methylglutaryl coenzyme A reductase in the liver of the rat. Comparison with the rate of cholesterol synthesis in different physiological states.
1979 StandoutNobel
Isoenzyme patterns in parenchymal and non-parenchymal cells isolated from regenerating and regenerated rat liver
1973
The Syndromes of Insulin Resistance and Acanthosis Nigricans
1976 Standout
The isolation of hormone-sensitive rat hepatocytes by a modified enzymatic technique
1974
Estimating the maximal potential for intestinal lymphatic transport of lipophilic drug molecules
1986
Reversible modulation of liver hydroxymethylglutaryl CoA reductase
1978
Drug-induced pancreatitis: A critical review
1980
Systemic Carnitine Deficiency — A Treatable Inherited Lipid-Storage Disease Presenting as Reye's Syndrome
1980
Cholangiocytes express the aquaporin CHIP and transport water via a channel-mediated mechanism.
1994 StandoutNobel
The Regulation of Gluconeogenesis in Isolated Rat Liver Cells by Glucagon, Insulin, Dibutyryl Cyclic Adenosine Monophosphate, and Fatty Acids
1972
Works of David M. Capuzzi being referenced
The Effects of Niacin on Lipoprotein Subclass Distribution
2004
Incremental reduction of serum total cholesterol and low-density lipoprotein cholesterol with the addition of plant stanol ester-containing spread to statin therapy
2000
Efficacy and safety of an extended-release niacin (niaspan): a long-term study
1998
Treatment of hyperlipidemia with combined niacin–statin regimens
1998
Effect of Xuezhikang, an Extract From Red Yeast Chinese Rice, on Coronary Events in a Chinese Population With Previous Myocardial Infarction
2008
Multiple-dose efficacy and safety of an extended-release form of niacin in the management of hyperlipidemia
2000
Rosuvastatin Alone or With Extended‐Release Niacin: A New Therapeutic Option for Patients With Combined Hyperlipidemia
2004
A new extended-release niacin (niaspan): efficacy, tolerability, and safety in hypercholesterolemic patients
1998
Plasma lipoproteins mediate platelet adhesion
1990
High-density lipoprotein subfractions and risk of coronary artery disease
2004
Scintigraphic Features of Autoimmune Thyroiditis
2001
Effects of extended-release niacin on lipoprotein subclass distribution
2003
Niacin dosing: Relationship to benefits and adverse effects
2000
Changing Concepts in the Management of Differentiated Thyroid Cancer
2005
Beneficial effects of rosuvastatin alone and in combination with extended-release niacin in patients with a combined hyperlipidemia and low high-density lipoprotein cholesterol levels
2003
Pathophysiology and treatment of the dyslipidemia of insulin resistance
2001
Hyperkalemia after triamterene in diabetic patients
1972
Effect of method of cell isolation on the metabolic activity of isolated rat liver cells
1972
Acute pancreatitis with hyperlipemia
1974
Liver lipid profiles of adults taking therapeutic doses of aspirin
1992
Inhibition of Lipid Synthesis by Epinephrine in Isolated Rat Liver Cells
1972
Interleukin-1α As a Factor in Occlusive Vascular Disease
1992
A Disorder of Muscle Lipid Metabolism and Myoglobinuria
1975
The Regulation of Lipogenesis by Cyclic Nucleotides in Intact Hepatocytes Prepared by a Simplified Technique
1974
Metabolic studies in isolated rat liver cells: II. Biosynthesis of serum low density lipoproteins and its regulation
1971
Treatment Effect of Niaspan, a Controlled-release Niacin, in Patients With Hypercholesterolemia: A Placebo-controlled Trial.
1996
Simplified method for isolation of intact avian and rat liver parencymal cells
1971
Thrombospondin Levels in Patients with Malignancy
1992
Acute Pancreatitis with Hyperlipemia
1973
Treatment Effect of Niaspan, a Controlled-release Niacin, in Patients with Hypercholesterolemia: A Placebo-controlled Trial
1996
Intestinal triglycerides are derived from both endogenous and exogenous sources
1985
Metabolism of 125I-labeled lipoproteins by the isolated rat lung.
1976
Metabolic studies in isolated rat liver cells: I. Lipid synthesis
1971